Emergent Faces Investor Suit Over Destroyed COVID Vaccines
Emergent Biosolutions and its top executives were hit with a proposed class action Wednesday brought by an investor alleging misrepresentations and omissions concerning quality control problems at the company's facility in...To view the full article, register now.
Already a subscriber? Click here to view full article